These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3932206

  • 1. Liver macrophages (Kupffer cells) as cytotoxic effector cells in extracellular and intracellular cytotoxicity.
    Decker T, Kiderlen AF, Lohmann-Matthes ML.
    Infect Immun; 1985 Nov; 50(2):358-64. PubMed ID: 3932206
    [Abstract] [Full Text] [Related]

  • 2. A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages.
    Scott P, Sher A.
    J Immunol; 1986 Feb 15; 136(4):1461-6. PubMed ID: 3511147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
    Hockmeyer WT, Walters D, Gore RW, Williams JS, Fortier AH, Nacy CA.
    J Immunol; 1984 Jun 15; 132(6):3120-5. PubMed ID: 6725948
    [Abstract] [Full Text] [Related]

  • 6. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR, Wasserman AJ, Laskin DL.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA.
    J Immunol; 1990 Dec 15; 145(12):4290-7. PubMed ID: 2124240
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
    Sypek JP, Wyler DJ.
    Infect Immun; 1990 May 15; 58(5):1146-52. PubMed ID: 2323812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
    Panosian CB, Sypek JP, Wyler DJ.
    J Immunol; 1984 Dec 15; 133(6):3358-65. PubMed ID: 6208278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.